Back to User profile » Dr Kimberly Redic
Paper published by Dr Kimberly Redic:
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor
Redic KA, Hough SM, Price EM
OncoTargets and Therapy 2016, 9:2783-2793
Published Date: 10 May 2016